Archive for the ‘Open Innovation’ Category


Aquaculture in Atlantic Canada

February 6th, 2009 by Hayley

saipal_marine_atlantic_1244372_lGenome Atlantic, a not-for-profit organisation, has received $3 million from ACOA’s Atlantic Innovation Fund to solve the aquaculture industry’s challenge of early maturation in cod.

Early maturation can account for significant financial losses due to increased production time and decreased product quality.

What makes this project different is combined expertise. 

The new C-ADAP3T project (Comparative Assessment of Diploid & Polyploid Physiology & Production Traits) will use genomics and selective breeding to develop sterile production fish to overcome the early maturation barrier.

Genome Atlantic led the development of this project, and will manage its overall progress.

The research component will be conducted with the region’s leading genomics and aquaculture researchers and resources from Fisheries and Oceans Canada’s St. Andrews Biological Station, Memorial University Ocean Sciences Centre, Cooke Aquaculture, the Huntsman Marine Science Centre, University of New Brunswick and University of Guelph.

The news article can be viewed here.

 


Peptide Biofouling Solutions for Aquaculture

December 1st, 2008 by Andrew

MariCal, of Portland, Maine is a privately held animal health and nutrition biotechnology company with a multi-patent technology platform that has a variety of applications in aquaculture.

A recent patent application notes that certain peptides can be incorporated in polymer formulations to prevent biofouling.

MariCal’s technology platform is built around the science of calcium sensing receptor proteins (CaSRs). MariCal’s key discovery is that of a class of molecular extracellular ion receptor proteins, called Calcium Receptors serve as the biological “thermostats,” or “master switches” that enable fish and other aquatic organisms to sense and respond to changes in both water salinity and nutrients in their aquatic environment.

MariCal’s Calcium Sensing Receptors have an array of existing interesting applications in aquaculture: 

  • In late June 2008 MariCal announced the exclusive global licensing of the Company’s smoltification technology, the SuperSmolt® Program, to Europharma to service the commercial salmon industry.
  • In addition, MariCal is a joint-venture partner in Low Salinity Inc., based in Saltville, Virginia – a land-based recirculation production and research facility for cobia.

MariCal states that amongst other things that its capabilities can be used to generate the following benefits in finfish aquaculture:

  • Add value with an all natural finishing process
    • permits fine-tuning of taste
    • increases fillet thickness
    • assures consistent taste/texture of aquacultured freshwater and saltwater fish
  • Increase yield for higher profit
  • Produce high value marine species in freshwater sites near major markets
  • Improved methods of producing and processing fish eggs for caviar and sushi markets

The discovery, development and deployment of MariCal’s calcium receptor science in aquaculture is an exceptional example of the cross boundary application of science to generate breakthroughs in an ‘unrelated field’ – one of the classical tennets of the practice of open innovation.

For a more extended discussion of the science behind Calcium Receptors, their role in humans, and how they function in aquatic organisms, click here for a PDF document.

Elements of Marical’s patent portfolio may be viewed here.

MariCal has operations in Chile, through its subsidiary CienciaMar, and offices in Canada, United Kingdom, and Norway.

To date, the Finfish site includes nine other posts which address issues related to fouling.  These may be accessed by clicking on this link or by conducting a search by typing your terms into the box on the top right hand corner of this page.


Fish Oil Can Help Congestive Heart Failure

November 16th, 2008 by Andrew

Here is a new published study showing that taking fish oil can reduce the risk of death in patients with heart failure. An Italian study showing the benefits of fish oil was just published in the Lancet (a prestigious medical journal). This study also showed that heart patients who take fish oil are less likely to be hospitalized.
The results show that those given the fish oil were 9% less likely to die during that 4 year period. The difference went from 9% to 14% when researchers examined the 5,000 patients who took the capsules once a day as directed (I think this means some patients didn’t take their medicine as directed). The number of those admitted to hospital for arrhythmias fell by 28% during the same period.

Luigi Tavazzi of the National Association of Hospital Cardiologists (Italy) said ”Our study shows that the long-term administration of one gram per day of omega-3 polyunsaturated fatty acid was effective in reducing both all-cause mortality and admissions to hospital for cardiovascular reasons.

More information can be found at: http://stem-cell-therapy.blogspot.com/2008/09/fish-oil-can-help-congestive-heart.html


Next Page »